拜玛林制药2024财年第三财季实现净利润1.06亿美元,同比增加162.51%

市场透视
03 Nov 2024

11月3日,拜玛林制药(BMRN.US)公布财报,公告显示公司2024财年第三财季净利润为1.06亿美元,同比增加162.51%;其中营业收入为7.42亿美元,同比增加26.62%,每股基本收益为0.56美元。从资产负债表来看,拜玛林制药(BMRN.US)总负债14.38亿美元,其中短期债务0.00美元,资产负债比为4.77,流动比率为4.27。机构评级:截至2024年11月3日,当前有25家机构...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10